HARDY ALEXANDER (Chief Executive Officer) received a stock award from BIOMARIN PHARMACEUTICAL INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/2/2025ACC: 0001628280-25-054856
DirectorOfficer· Chief Executive Officer
Since Dec 2023
-16.20K
Net shares
Net seller
$911.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
375.00 acquired · 16.57K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+375.00
Price / share
$54.14
Trade value
$20.30K
% of position
0.2%
4/30/2025
175.58K→175.96K
Common Stock
Direct
Shares
−16.57K
Price / share
$55.03
Trade value
$911.85K
% of position
9.4%
12/1/2025
175.96K→159.39K
Total
Net shares
−16.20K
Net value
-$891.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2025 | A · Award | +375.00 | $54.14 | $20.30K | 0.2% | 175.58K | 175.96K |
| Common Stock Direct | 12/1/2025 | F · Tax Withholding | −16.57K | $55.03 | $911.85K | 9.4% | 175.96K | 159.39K |
| Total | −16.20K | -$891.55K | ||||||
Derivative Transactions0
No derivative transactions reported